HTA95 Cost-Effectiveness Analysis of RSVpreF Vaccine for RSV Prevention in Older Adults Under Situation of the National Vaccination Program in Taiwan: A Study on Economic and Clinical Advantages
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.1880
https://www.valueinhealthjournal.com/article/S1098-3015(25)04437-7/fulltext
Title :
HTA95 Cost-Effectiveness Analysis of RSVpreF Vaccine for RSV Prevention in Older Adults Under Situation of the National Vaccination Program in Taiwan: A Study on Economic and Clinical Advantages
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)04437-7&doi=10.1016/j.jval.2025.09.1880
First page :
Section Title :
Open access? :
No
Section Order :
11424